Quarterly ResultAug 12, 2026, 05:19 PM
Ascend Wellness Q2 Net Loss $9.8M; Revenue $126.1M; Acquisitions
AI Summary
Ascend Wellness Holdings reported a net loss of $9.8 million for Q2 2026, a significant improvement from $24.4 million in Q2 2025, despite a slight revenue decrease to $126.1 million. For the six months, net loss was $39.3 million on revenue of $243.1 million. The company continued its expansion strategy with new acquisitions, including Northeast Partnership Dispensaries Seven and Eight for $3.6 million and Midwest Partnership Two Dispensaries for $22.3 million. Cash and cash equivalents stood at $67.0 million as of June 30, 2026.
Key Highlights
- Q2 2026 net loss improved to $9.8 million from $24.4 million in Q2 2025.
- Q2 2026 revenue decreased to $126.1 million from $127.3 million year-over-year.
- Operating profit for Q2 2026 was $5.3 million, up from a $1.0 million loss year-over-year.
- Acquired Northeast Partnership Dispensaries Seven and Eight for $3.6 million.
- Acquired Midwest Partnership Two Dispensaries for $22.3 million.
- Cash and cash equivalents totaled $67.0 million as of June 30, 2026.
- Net cash provided by operating activities for six months was $3.0 million.
Price Impact
More from AAWH